Skip to main content
Clinical Trials/CTRI/2024/05/067772
CTRI/2024/05/067772Not yet recruitingPhase 3

To understand the Miasmatic background and effectiveness of homoeopathic treatment in cases of Allergic Rhinitis

Dr Bhumikakumari S Gamit1 site in 1 country30 target enrollmentStarted: June 1, 2024Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Score For Allergic Rhinitis is validated questionnaire introduce in 2002 by the Annesi-Maesano group

Study Overview

Brief Summary

As I’ve observed prevalence of Allergic Rhinitis , probable adverse effects of allopathic management,the homoeopathic view for its probable causation (miasmatic)& its possible management with homoeopathic medicines -this study aims to understanding the Miasmatic background and its therapeutic implication in management of cases of Allergic Rhinitis, through a broader aspect, taking into consideration the holistic approach of Homoeopathy and provide gentle relief/cure.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
0.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Prediagnosed cases or cases with clinical presentation of the Allergic Rhinitis.
  • Cases with functional changes or with reversible pathology.
  • Those patients already on allopathic treatment,but now convinced to take Homoeopathic treatment.

Exclusion Criteria

  • Cases with severe systemic disease and irreversible pathology.

Outcomes

Primary Outcomes

Score For Allergic Rhinitis is validated questionnaire introduce in 2002 by the Annesi-Maesano group

Time Frame: As per requirement of cases till 9 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr Bhumikakumari S Gamit
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

DR BHUMIKAKUMARI S GAMIT

Dr V H Dave Homoeopathic Medical College

Study Sites (1)

Loading locations...

Similar Trials